grade
pharmaceutical primary standard
API family
isoflurane
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
FC(F)(F)C(Cl)OC(F)F
InChI
1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H
InChI key
PIWKPBJCKXDKJR-UHFFFAOYSA-N
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Isoflurane EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Biochem/physiol Actions
Isoflurane is a tandem pore potassium channel activator.
Isoflurane is a tandem pore potassium channel activator. It is also a very widely used anesthetic for animal research and for in vitro studies on anesthesia mechanisms.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
signalword
Warning
hcodes
Hazard Classifications
STOT SE 3
target_organs
Central nervous system
저장 등급
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Oliver Grottke et al.
Critical care (London, England), 18(1), R27-R27 (2014-02-07)
New oral anticoagulants are effective alternatives to warfarin. However, no specific reversal agents are available for life-threatening bleeding or emergency surgery. Using a porcine model of trauma, this study assessed the ability of prothrombin complex concentrate (PCC), activated PCC (aPCC)
Yanlin Jia et al.
Nature communications, 5, 4387-4387 (2014-07-19)
Injury to lung epithelial cells has a role in multiple lung diseases. We previously identified mitsugumin 53 (MG53) as a component of the cell membrane repair machinery in striated muscle cells. Here we show that MG53 also has a physiological
Qiaoya Lin et al.
Small (Weinheim an der Bergstrasse, Germany), 10(15), 3072-3082 (2014-04-08)
The abilities to deliver siRNA to its intended action site and assess the delivery efficiency are challenges for current RNAi therapy, where effective siRNA delivery will join force with patient genetic profiling to achieve optimal treatment outcome. Imaging could become
국제 무역 품목 번호
| SKU | GTIN |
|---|---|
| Y0000858 | 04061837583926 |